Skip to content
User

Nicolai Tangen

AKO Capital

Nicolai Tangen Colgate-Palmolive Company stake

total: 72

AKO Capital CL trades

Total transactions:
9
New positions:
1
Sold out:
1
Added:
5
Reduced:
2
Held since:
2016 Q4
Held for:
8 quarters
Latest activity:
2018 Q4
According to 2026 Q2 report, Nicolai Tangen doesn't hold any Colgate-Palmolive Company (CL) shares. To date, the estimated cost basis is nearly $67.19 for "buy" trades and estimated average "sell" price is $67.47. AKO Capital first purchased CL in 2016 Q4, initially acquiring 583,223 shares. Since the initial investment in Colgate-Palmolive Company (CL), AKO Capital has made 8 more transactions.

When did Nicolai Tangen sell Colgate-Palmolive Company (CL)?

Nicolai Tangen sold off the entire Colgate-Palmolive Company (CL) position in 2018 Q4.

When did Nicolai Tangen buy Colgate-Palmolive Company (CL)?

Nicolai Tangen first invested in Colgate-Palmolive Company (CL) in 2016 Q4 at the reported quarter-end price of $65.44 per share.

What's the cost basis of AKO Capital's CL stake?

The estimated cost basis for Colgate-Palmolive Company (CL) stake is around $67.19 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$67.19
Weighted AVG sell price:
$67.47

Nicolai Tangen's historical trades in Colgate-Palmolive Company

9 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2018 Q4
0.00%
$66.95
-100% (-879,383)
2018 Q3
3.00%
$66.95
+16.59% (+125,124)
2018 Q2
2.64%
$64.81
+9.10% (+62,927)
2018 Q1
2.93%
$71.68
+13.82% (+83,960)
2017 Q4
3.56%
$75.45
+17.92% (+92,292)
2017 Q3
3.08%
$72.85
+2.29% (+11,512)
2017 Q2
3.31%
$74.13
-0.63% (-3,208)
2017 Q1
3.33%
$73.19
-13.11% (-76,447)
2016 Q4
4.90%
$65.44
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.